CATALYST DOSSIER · UPDATED 2026-11-05
$IPDN
tech · convergence 0 · conviction WATCH
Price & Live Quote Loading live quote & chart…
Practice trade tools Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.
Paper trade unavailable: missing risk-bounded frame
Reference only. Not financial advice. No brokerage order is placed.
Why $IPDN?
Quantitative
Net Income (CY2026Q2) : $-1.7M (-259.3% YoY)
Catalysts
Multi-spoke convergence : 6 convergent signals fired: earnings, pill, auto_sec_poison_pill, auto_macro_adp_payrolls, auto_macro_durable_goods
Risks
Position-sizing discipline : Conviction WATCH (0 score) — size accordingly; no specific catalyst-fade risk flagged
Bear case
Earnings binary : Print-day moves can swing ±15% — gap risk both directions
Sympathy basket (cerebro)
SHLS via semis r=+0.89 sympathetic (score 25)
NVDA via semis r=+0.89 sympathetic (score 16)
CRIS via biotech r=+0.81 sympathetic (score 30)
BLLN via biotech r=+0.81 sympathetic (score 24)
LBTYA via comms r=+0.57 sympathetic (score 20)
CHTR via comms r=+0.57 sympathetic (score 19)
Signals Firing
earnings pill auto_sec_poison_pill auto_macro_adp_payrolls auto_macro_durable_goods auto_macro_fx_rates
Pick Track Record Date List Next-day max run Next-day close Hit +2%? 2026-10-21 sec_top_gappers +1.5% -3.4% — 2026-10-21 sec_top_moat_emerging +1.5% -3.4% — 2026-10-19 sec_top_gappers +8.0% +2.0% ✓ hit 2026-10-19 sec_top_moat_emerging +8.0% +2.0% ✓ hit 2026-10-02 sec_top_gappers -0.6% -3.7% — 2026-10-02 sec_top_moat_emerging -0.6% -3.7% — 2026-09-11 sec_top_gappers +3000.0% +2808.3% ✓ hit 2026-09-11 sec_top_moat_emerging +3000.0% +2808.3% ✓ hit
Lifetime: 4/8 wins · hit-rate 50.0% on +2% intraday
Sympathy Basket SHLS via semis · score 25 NVDA via semis · score 16 CRIS via biotech · score 30 BLLN via biotech · score 24 LBTYA via comms · score 20 CHTR via comms · score 19
Earnings Catalyst No recent earnings event.
Generate full earnings report
Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks
and its losses — see the
trust report and
methodology .
Not financial advice. Confirm independently before trading.